ArticlePloS one2013

HIV-1 diversity, drug-resistant mutations, and viral evolution among high-risk individuals in phase II HIV vaccine trial sites in southern China.

Haiyan Qi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.